AC Immune SA

AC Immune SA (ACIU) shows no cyber incidents or red-flag 8-K filings in our 90-day monitoring window, presenting a clean recent compliance record. However, a low-signal period does not indicate low risk—the company operates in the biotech sector where clinical trial outcomes and financing decisions carry material weight. The full $49 Report extends analysis to 12 months of filing history, calculates dilution risk from equity raises and warrant activity, maps 8-K context around financing events, and surfaces AI-detected risk signals in earnings calls and SEC filings. The full $49 Report adds quantified dilution scoring, 12-month event timeline, and sector-specific risk signals tied to pipeline and capital structure.